Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours
Clinical trial NCT00716417 · COMPLETED
Trial details
- NCT number
- NCT00716417
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-07-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.